Psychostimulants and brain dysfunction: A review of the relevant neurotoxic effects

Neuropharmacology

Volumn 87, Issue , 2014, Pages 135-149

  Gonçalves, Joana ^a   Baptista, Sofia ^a   Silva, Ana Paula ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Blood brain barrier; Neurogenesis; Neuroinflammation; Neurotoxicity; Psychostimulants

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 AMINOBUTYRIC ACID; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPA RECEPTOR ANTAGONIST; AMPHETAMINE; ANTIOXIDANT; ASCORBIC ACID; COCAINE; DIZOCILPINE; DOPAMINE; FLUOXETINE; HALOPERIDOL; KETOPROFEN; METHAMPHETAMINE; METHYLPHENIDATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PSYCHOSTIMULANT AGENT; SCAVENGER; SEROTONIN; SULPIRIDE; CENTRAL STIMULANT AGENT;

BLOOD BRAIN BARRIER; BODY TEMPERATURE; BRAIN DYSFUNCTION; COCAINE DEPENDENCE; COGNITIVE DEFECT; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINERGIC SYSTEM; DRUG ABUSE; DRUG EFFECT; EXCITOTOXICITY; GABAERGIC SYSTEM; HUMAN; HYPERACTIVITY; HYPERTHERMIA; MEMORY DISORDER; MONOAMINERGIC SYSTEM; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; REVIEW; SEROTONINERGIC SYSTEM; ANIMAL; BRAIN; DRUG EFFECTS; PATHOPHYSIOLOGY; TOXICITY AND INTOXICATION;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS; NEUROTOXICITY SYNDROMES;

EID: 84908506648     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.01.006     Document Type: Review

References (233)

1. P.M. Abdul-Muneer, S. Alikunju, A.M. Szlachetka, L.C. Murrin, and J. Haorah Impairment of brain endothelial glucose transporter by methamphetamine causes blood-brain barrier dysfunction Mol. Neurodegener. 6 2011 23
2. O. Acikgoz, S. Gonenc, S. Gezer, B.M. Kayatekin, N. Uysal, I. Semin, and A. Gure Methamphetamine causes depletion of glutathione and an increase in oxidized glutathione in the rat striatum and prefrontal cortex Neurotox. Res. 3 2001 277 280
3. S.F. Ali, G.D. Newport, R.R. Holson, W. Slikker Jr., and J.F. Bowyer Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice Brain Res. 658 1-2 1994 33 38
4. E. Alves, Z. Binienda, F. Carvalho, C.J. Alvesm, E. Fernandesm, M. de Lourdes Bastos, M.A. Tavares, and T. Summavielle Acetyl-L-carnitine provides effective in vivo neuroprotection over 3,4-methylenedioximethamphetamine-induced mitochondrial neurotoxicity in the adolescent rat brain Neuroscience 158 2009 514 523
5. E. Alves, T. Summavielle, C.J. Alves, J. Gomes-da-Silva, J.C. Barata, E. Fernandes, L. Bastos Mde, M.A. Tavares, and F. Carvalho Monoamine oxidase-B mediates ecstasy-induced neurotoxic effects to adolescent rat brain mitochondria J. Neurosci. 27 2007 10203 10210
6. K.L. Anderson, and Y. Itzhak Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse Ann. N. Y. Acad. Sci. 1074 2006 225 233
7. J.H. Anneken, and G.A. Gudelsky MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus Neuropharmacology 63 2012 1022 1027
8. J.H. Anneken, J.I. Cunningham, S.A. Collins, B.K. Yamamoto, and G.A. Gudelsky MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase J. Neuroimmune Pharmacol. 8 2013 58 65
9. H. Aujla, R. Martin-Fardon, and F. Weiss Rats with extended access to cocaine exhibit increased stress reactivity and sensitivity to the anxiolytic-like effects of the mGluR 2/3 agonist LY379268 during abstinence Neuropsychopharmacology 33 2008 1818 1826
10. A.J. Avelar, S.A. Juliano, and P.A. Garris Amphetamine augments vesicular dopamine release in the dorsal and ventral striatum through different mechanisms J. Neurochem. 125 2013 373 385
11. R.B. Badisa, and C.B. Goodman Effects of chronic cocaine in rat C6 astroglial cells Int. J. Mol. Med. 30 2012 687 692
12. M. Bahcelioglu, R. Gozil, G. Take, C. Elmas, H. Oktem, D. Kadioglu, E. Calguner, D. Erdogan, M.F. Sargon, A.C. Yazici, M. Tas, Y. Bardakci, and S. Senol Dose-related immunohistochemical and ultrastructural changes after oral methylphenidate administration in cerebrum and cerebellum of the rat World J. Biol. Psychiatry 10 2009 531 543
13. F. Bai, D.C. Jones, S.S. Lau, and T.J. Monks Serotonergic neurotoxicity of 3,4-(+/-)-methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase Chem. Res. Toxicol. 14 2001 863 870
14. S. Baptista, A.R. Bento, J. Goncalves, L. Bernardino, T. Summavielle, A. Lobo, C. Fontes-Ribeiro, J.O. Malva, F. Agasse, and A.P. Silva Neuropeptide Y promotes neurogenesis and protection against methamphetamine-induced toxicity in mouse dentate gyrus-derived neurosphere cultures Neuropharmacology 62 2012 2413 2423
15. D.J. Barbosa, J.P. Capela, J.M. Oliveira, R. Silva, L.M. Ferreira, F. Siopa, P.S. Branco, E. Fernandes, J.A. Duarte, M. de Lourdes Bastos, and F. Carvalho Pro-oxidant effects of ecstasy and its metabolites in mouse brain synaptosomes Br. J. Pharmacol. 165 2012 1017 1033
16. J.L. Barr, K.J. Renner, and G.L. Forster Withdrawal from chronic amphetamine produces persistent anxiety-like behavior but temporally-limited reductions in monoamines and neurogenesis in the adult rat dentate gyrus Neuropharmacology 59 2010 395 405
17. V. Bashkatova, J. Meunier, A. Vanin, and T. Maurice Nitric oxide and oxidative stress in the brain of rats exposed in utero to cocaine Ann. N. Y. Acad. Sci. 1074 2006 632 642
18. J.E. Bauwens, J.M. Boggs, and P.S. Hartwell Fatal hyperthermia associated with cocaine use West. J. Med. 150 1989 210 212
19. R.M. Bauzo, H.L. Kimmel, and L.L. Howell Interactions between the mGluR2/3 agonist, LY379268, and cocaine on in vivo neurochemistry and behavior in squirrel monkeys Pharmacol. Biochem. Behav. 94 2009 204 210
20. O. Ben-Shahar, P. Keeley, M. Cook, W. Brake, M. Joyce, M. Nyffeler, R. Heston, and A. Ettenberg Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine Brain Res. 1131 2007 220 228
21. A.R. Bento, S. Baptista, J.O. Malva, A.P. Silva, and F. Agasse Methamphetamine exerts toxic effects on subventricular zone stem/progenitor cells and inhibits neuronal differentiation Rejuvenation Res. 14 2011 205 214
22. T.J. Beveridge, H.R. Smith, M.A. Nader, and L.J. Porrino Group II metabotropic glutamate receptors in the striatum of non-human primates: dysregulation following chronic cocaine self-administration Neurosci. Lett. 496 2011 15 19
23. I.L. Bogen, K.H. Haug, O. Myhre, and F. Fonnum Short- and long-term effects of MDMA ("ecstasy") on synaptosomal and vesicular uptake of neurotransmitters in vitro and ex vivo Neurochem. Int. 43 2003 393 400
24. J. Booij, K. de Bruin, and W.B. Gunning Repeated administration of D-amphetamine induces loss of [123I]FP-CIT binding to striatal dopamine transporters in rat brain: a validation study Nucl. Med. Biol. 33 2006 409 411
25. J.F. Bowyer The role of hyperthermia in amphetamine's interactions with NMDA receptors, nitric oxide, and age to produce neurotoxicity Ann. N. Y. Acad. Sci. 765 1995 309 310
26. J.F. Bowyer, and S. Ali High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus Synapse 60 2006 521 532
27. J.F. Bowyer, A.R. Pogge, R.R. Delongchamp, J.P. O'Callaghan, K.M. Patel, K.E. Vrana, and W.M. Freeman A threshold neurotoxic amphetamine exposure inhibits parietal cortex expression of synaptic plasticity-related genes Neuroscience 144 2007 66 76
28. J.F. Bowyer, M. Thomas, L.C. Schmued, and S.F. Ali Brain region-specific neurodegenerative profiles showing the relative importance of amphetamine dose, hyperthermia, seizures, and the blood-brain barrier Ann. N. Y. Acad. Sci. 1139 2008 127 139
29. J.M. Brown, M.S. Quinton, and B.K. Yamamoto Methamphetamine-induced inhibition of mitochondrial complex II: roles of glutamate and peroxynitrite J. Neurochem. 95 2005 429 436
30. T.E. Brown, B.R. Lee, and B.A. Sorg The NMDA antagonist MK-801 disrupts reconsolidation of a cocaine-associated memory for conditioned place preference but not for self-administration in rats Learn. Mem. 15 2008 857 865
31. K.B. Burrows, G. Gudelsky, and B.K. Yamamoto Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-Methylenedioxymethamphetamine administration Eur. J. Pharmacol. 398 2000 11 18
32. J.L. Cadet, S.V. Ordonez, and J.V. Ordonez Methamphetamine induces apoptosis in immortalized neural cells: protection by the proto-oncogene, bcl-2 Synapse 25 1997 176 184
33. J.L. Cadet, S. Jayanthi, and X. Deng Methamphetamine-induced neuronal apoptosis involves the activation of multiple death pathways Neurotox. Res. 8 2005 199 206
34. J.L. Cadet, and I.N. Krasnova Molecular bases of methamphetamine-induced neurodegeneration Int. Rev. Neurobiol. 88 2009 101 119
35. P.D. Callaghan, W.A. Owens, M.A. Javors, T.A. Sanchez, D.J. Jones, R.J. Irvine, and L.C. Daws In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-Methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function J. Neurochem. 100 2007 617 627
36. R. Camarini, W.C. Griffin 3rd, A.B. Yanke, B. Rosalina dos Santos, and M.F. Olive Effects of adolescent exposure to cocaine on locomotor activity and extracellular dopamine and glutamate levels in nucleus accumbens of DBA/2J mice Brain Res. 1193 2008 34 42
37. J.P. Capela, H. Carmo, F. Remião, M.L. Bastos, A. Meisel, and F. Carvalho Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview Mol. Neurobiol. 39 2009 210 271
38. G.D. Cappon, L.L. Morford, and C.V. Vorhees Enhancement of cocaine-induced hyperthermia fails to elicit neurotoxicity Neurotoxicol. Teratol. 20 1998 531 535
39. C. Carlsson, and B.B. Johansson Blood-brain barrier dysfunction after amphetamine administration in rats Acta Neuropathol. 41 1978 125 129
40. M. Carvalho, H. Carmo, V.M. Costa, J.P. Capela, H. Pontes, F. Remiao, F. Carvalho, and L. Bastos Mde Toxicity of amphetamines: an update Arch. Toxicol. 86 2012 1167 1231
41. B.J. Catlow, K.A. Badanich, A.E. Sponaugle, A.R. Rowe, S. Song, I. Rafalovich, V. Sava, C.L. Kirstein, and J. Sanchez-Ramos Effects of MDMA ("ecstasy") during adolescence on place conditioning and hippocampal neurogenesis Eur. J. Pharmacol. 628 2010 96 103
42. C.N. Cearley, K. Blindheim, B.A. Sorg, J.M. Krueger, and L. Churchill Acute cocaine increases interleukin-1β mRNA and immunoreactive cells in the cortex and nucleus accumbens Neurochem. Res. 36 2011 686 692
43. K.O. Cho, G.S. Rhee, S.J. Kwack, S.Y. Chung, and S.Y. Kim Developmental exposure to 3,4-Methylenedioxymethamphetamine results in downregulation of neurogenesis in the adult mouse hippocampus Neuroscience 154 2008 1034 1041
44. V. Coelho-Santos, J. Goncalves, C. Fontes-Ribeiro, and A.P. Silva Prevention of methamphetamine-induced microglial cell death by TNF-alpha and IL-6 through activation of the JAK-STAT pathway J. Neuroinflamm. 9 2012 103
45. B.M. Costa, H. Yao, L. Yang, and S. Buch Role of endoplasmic reticulum (ER) stress in cocaine-induced microglial cell death J. Neuroimmune Pharmacol. 8 2013 705 714
46. T. Cunha-Oliveira, A.C. Rego, S.M. Cardoso, F. Borges, R.H. Swerdlow, T. Macedo, and C.R. de Oliveira Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine Brain Res. 1089 2006 44 54
47. E.C. Dabe, P. Majdak, T.K. Bhattacharya, D.S. Miller, and J.S. Rhodes Chronic D-amphetamine administered from childhood to adulthood dose-dependently increases the survival of new neurons in the hippocampus of male C57BL/6J mice Neuroscience 231 2013 125 135
48. C. Davidson, A.J. Gow, T.H. Lee, and E.H. Ellinwood Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment Brain Res. Brain Res. Rev. 36 2001 1 22
49. S. Dey, and D.M. Snow Cocaine exposure in vitro induces apoptosis in fetal locus coeruleus neurons through TNF-alpha-mediated induction of Bax and phosphorylated c-Jun NH(2)-terminal kinase J. Neurochem. 103 2007 542 556
50. N.K. Dhillon, F. Peng, S. Bokhari, S. Callen, S.H. Shin, X. Zhu, K.J. Kim, and S.J. Buch Cocaine-mediated alteration in tight junction protein expression and modulation of CCL2/CCR2 axis across the blood-brain barrier: implications for HIV-dementia J. Neuroimmune Pharmacol. 3 2008 52 56
51. J.B. Dietrich, R. Poirier, D. Aunis, and J. Zwiller Cocaine downregulates the expression of the mitochondrial genome in rat brain Ann. N. Y. Acad. Sci. 1025 2004 345 350
52. J.B. Dietrich, A. Mangeol, M.O. Revel, C. Burgun, D. Aunis, and J. Zwiller Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures Neuropharmacology 48 2005 965 974
53. J.B. Dietrich Alteration of blood-brain barrier function by methamphetamine and cocaine Cell Tissue Res. 336 2009 385 392
54. L. Domínguez-Escribà, V. Hernández-Rabaza, M. Soriano-Navarro, J.A. Barcia, F.J. Romero, J.M. García-Verdugo, and J.J. Canales Chronic cocaine exposure impairs progenitor proliferation but spares survival and maturation of neural precursors in adult rat dentate gyrus Eur. J. Neurosci. 24 2006 586 594
55. S. Duong, K. Chung, and S.B. Wigal Metabolic, toxicological, and safety considerations for drugs used to treat ADHD Expert Opin. Drug Metab. Toxicol. 8 2012 543 552
56. M.B. El-Ghundi, T. Fan, J.M. Karasinska, J. Yeung, M. Zhou, B.F. O'Dowd, and S.R. George Restoration of amphetamine-induced locomotor sensitization in dopamine D1 receptor-deficient mice Psychopharmacology (Berl) 207 2010 599 618
57. R.A. España, D.C. Roberts, and S.R. Jones Short-acting cocaine and long-acting GBR-12909 both elicit rapid dopamine uptake inhibition following intravenous delivery Neuroscience 155 2008 250 257
58. A.O. Fagundes, G.T. Rezin, F. Zanette, E. Grandi, L.C. Assis, F. Dal-Pizzol, J. Quevedo, and E.L. Streck Chronic administration of methylphenidate activates mitochondrial respiratory chain in brain of young rats Int. J. Dev. Neurosci. 25 2007 47 51
59. A.O. Fagundes, M.R. Aguiar, C.S. Aguiar, G. Scaini, M.U. Sachet, N.M. Bernhardt, G.T. Rezin, S.S. Valvassori, J. Quevedo, and E.L. Streck Effect of acute and chronic administration of methylphenidate on mitochondrial respiratory chain in the brain of young rats Neurochem. Res. 35 2010 1675 1680
60. A.O. Fagundes, G. Scaini, P.M. Santos, M.U. Sachet, N.M. Bernhardt, G.T. Rezin, S.S. Valvassori, P.F. Schuck, J. Quevedo, and E.L. Streck Inhibition of mitochondrial respiratory chain in the brain of adult rats after acute and chronic administration of methylphenidate Neurochem. Res. 35 2010 405 411
61. W.E. Fantegrossi, J.R. Ciullo, K.T. Wakabayashi, R. De La Garza 2nd, J.R. Traynor, and J.H. Woods A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-Methylenedioxymethamphetamine in the mouse Neuroscience 151 2008 533 543
62. G. Feier, S.S. Valvassori, J. Lopes-Borges, R.B. Varela, D.V. Bavaresco, G. Scaini, M.O. Morais, M.L. Andersen, E.L. Streck, and J. Quevedo Behavioral changes and brain energy metabolism dysfunction in rats treated with methamphetamine or dextroamphetamine Neurosci. Lett. 530 2012 75 79
63. M. Fiala, A.J. Eshleman, J. Cashman, J. Lin, A.S. Lossinsky, V. Suarez, W. Yang, J. Zhang, W. Popik, E. Singer, F. Chiappelli, E. Carro, M. Weinand, M. Witte, and J. Arthos Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells J. Neurovirol. 11 2005 281 291
64. M. Fiala, E.J. Singer, D. Commins, T. Mirzapoiazova, A. Verin, A. Espinosa, K. Ugen, M. Bernas, M. Witte, M. Weinand, and A.S. Lossinsky HIV-1 antigens in neurons of cocaine-abusing patients Open Virol. J. 2 2008 24 31
65. P.S. Fitzmaurice, J. Tong, M. Yazdanpanah, P.P. Liu, K.S. Kalasinsky, and S.J. Kish Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine J. Pharmacol. Exp. Ther. 319 2006 703 709
66. A.E. Fleckenstein, T.J. Volz, E.L. Riddle, J.W. Gibb, and G.R. Hanson New insights into the mechanism of action of amphetamines Annu. Rev. Pharmacol. Toxicol. 47 2007 681 698
67. L. Frau, N. Simola, A. Plumitallo, and M. Morelli Microglial and astroglial activation by 3,4-Methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility J. Neurochem. 124 2013 69 78
68. L. Freese, E.J. Muller, M.F. Souza, N.S. Couto-Pereira, C.F. Tosca, M. Ferigolo, and H.M. Barros GABA system changes in methylphenidate sensitized female rats Behav. Brain Res. 231 2012 181 186
69. B.N. Frey, M.R. Martins, F.C. Petronilho, F. Dal-Pizzol, J. Quevedo, and F. Kapczinski Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania Bipolar Disord. 8 2006 275 280
70. B.N. Frey, S.S. Valvassori, K.M. Gomes, M.R. Martins, F. Dal-Pizzol, F. Kapczinski, and J. Quevedo Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure Brain Res. 1097 2006 224 229
71. M.E. Fritts, K. Mueller, and L. Morris Amphetamine-induced locomotor stereotypy in rats is reduced by a D1 but not a D2 antagonist Pharmacol. Biochem. Behav. 58 1997 1015 1019
72. A. Gabriele, A.M. Pacchioni, and R.E. See Dopamine and glutamate release in the dorsolateral caudate putamen following withdrawal from cocaine self-administration in rats Pharmacol. Biochem. Behav. 103 2012 373 379
73. X. Gan, L. Zhang, O. Berger, M.F. Stins, D. Way, D.D. Taub, S.L. Chang, K.S. Kim, S.D. House, M. Weinand, M. Witte, M.C. Graves, and M. Fiala Cocaine enhances brain endothelial adhesion molecules and leukocyte migration Clin. Immunol. 91 1999 68 76
74. N. Gandhi, Z.M. Saiyed, J. Napuri, T. Samikkannu, P.V. Reddy, M. Agudelo, P. Khatavkar, S.K. Saxena, and M.P. Nair Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorder J. Neurovirol. 16 2010 294 305
75. M.J. García-Fuster, S.B. Flagel, S.T. Mahmood, L.M. Mayo, R.C. Thompson, S.J. Watson, and H. Akil Decreased proliferation of adult hippocampal stem cells during cocaine withdrawal: possible role of the cell fate regulator FADD Neuropsychopharmacology 36 2011 2303 2317
76. K.E. Gill, P.J. Pierre, J. Daunais, A.J. Bennett, S. Martelle, H.D. Gage, J.M. Swanson, M.A. Nader, and L.J. Porrino Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates Neuropsychopharmacology 37 2012 2555 2565
77. M.R. Gluck, L.Y. Moy, E. Jayatilleke, K.A. Hogan, L. Manzino, and P.K. Sonsalla Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment J. Neurochem. 79 2001 152 160
78. L.S. Goldman, M. Genel, R.J. Bezman, and P.J. Slanetz Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association JAMA 279 1998 1100 1107
79. K.M. Gomes, F.C. Petronilho, M. Mantovani, T. Garbelotto, C.R. Boeck, F. Dal-Pizzol, and J. Quevedo Antioxidant enzyme activities following acute or chronic methylphenidate treatment in young rats Neurochem. Res. 33 2008 1024 1027
80. J. Gonçalves, T. Martins, R. Ferreira, N. Milhazes, F. Borges, C.F. Ribeiro, J.O. Malva, T.R. Macedo, and A.P. Silva Methamphetamine-induced early increase of IL-6 and TNF-alpha mRNA expression in the mouse brain Ann. N. Y. Acad. Sci. 1139 2008 103 111
81. J. Gonçalves, S. Baptista, T. Martins, N. Milhazes, F. Borges, C.F. Ribeiro, J.O. Malva, and A.P. Silva Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin Eur. J. Neurosci. 31 2010 315 326
82. B. Goni-Allo, B.O. Mathúna, M. Segura, E. Puerta, B. Lasheras, R. de la Torre, and N. Aguirre The relationship between core body temperature and 3,4-Methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity Psychopharmacology (Berl) 197 2008 263 278
83. R.W. Gould, H.D. Gage, M.L. Banks, B.L. Blaylock, P.W. Czoty, and M.A. Nader Differential effects of cocaine and MDMA self-administration on cortical serotonin transporter availability in monkeys Neuropharmacology 61 2011 245 251
84. N.B. Gross, and J.F. Marshall Striatal dopamine and glutamate receptors modulate methamphetamine-induced cortical Fos expression Neuroscience 161 2009 1114 1125
85. Y. Hagino, Y. Takamatsu, H. Yamamoto, T. Iwamura, D.L. Murphy, G.R. Uhl, I. Sora, and K. Ikeda Effects of MDMA on extracellular dopamine and serotonin levels in mice lacking dopamine and/or serotonin transporters Curr. Neuropharmacol. 9 2011 91 95
86. S. Hamarman, J. Fossella, C. Ulger, M. Brimacombe, and J. Dermody Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: a pharmacogenetic study J. Child Adolesc. Psychopharmacol. 14 4 2004 564 574
87. R.C. Harvey, S. Sen, A. Deaciuc, L.P. Dwoskin, and K.M. Kantak Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function Neuropsychopharmacology 36 2011 837 847
88. Z. He, L. Yan, Z. Yong, Z. Dong, H. Dong, and Z. Gong Chicago sky blue 6B, a vesicular glutamate transporters inhibitor, attenuates methamphetamine-induced hyperactivity and behavioral sensitization in mice Behav. Brain Res. 239 2013 172 176
89. M.G. Henderson, and B.A. McMillen Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat offspring after in utero exposure to cocaine or related drugs Teratology 48 1993 421 430
90. D.V. Herin, M.J. Bubar, P.K. Seitz, M.L. Thomas, G.R. Hillman, Y.I. Tarasenko, P. Wu, and K.A. Cunningham Elevated expression of serotonin 5-HT(2A) receptors in the rat ventral tegmental area enhances vulnerability to the behavioral effects of cocaine Front. Psychiatry 4 2013 2
91. V. Hernández-Rabaza, L. Domínguez-Escribà, J.A. Barcia, J.F. Rosel, F.J. Romero, J.M. García-Verdugo, and J.J. Canales Binge administration of 3,4-Methylenedioxymethamphetamine ("ecstasy") impairs the survival of neural precursors in adult rat dentate gyrus Neuropharmacology 51 2006 967 973
92. N.R. Herring, G.A. Gudelsky, C.V. Vorhees, and M.T. Williams (+)-Methamphetamine-induced monoamine reductions and impaired egocentric learning in adrenalectomized rats is independent of hyperthermia Synapse 64 2010 773 785
93. M. Higuchi, Y. Suzuki, Y. Yatani, Y. Kitagawa, K. Nagayasu, H. Shirakawa, T. Nakagawa, and S. Kaneko Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons J. Neurochem. 106 2008 2410 2420
94. J.R. Homberg, S.F. De Boer, H.S. Raasø, J.D. Olivier, M. Verheul, E. Ronken, A.R. Cools, B.A. Ellenbroek, A.N. Schoffelmeer, L.J. Vanderschuren, T.J. De Vries, and E. Cuppen Adaptations in pre- and postsynaptic 5-HT1A receptor function and cocaine supersensitivity in serotonin transporter knockout rats Psychopharmacology (Berl) 200 2008 367 380
95. L.L. Howell, F.I. Carroll, J.R. Votaw, M.M. Goodman, and H.L. Kimmel Effects of combined dopamine and serotonin transporter inhibitors on cocaine self-administration in rhesus monkeys J. Pharmacol. Exp. Ther. 320 2007 757 765
96. S. Hu, M.C. Cheeran, W.S. Sheng, H.T. Ni, J.R. Lokensgard, and P.K. Peterson Cocaine alters proliferation, migration, and differentiation of human fetal brain-derived neural precursor cells J. Pharmacol. Exp. Ther. 318 2006 1280 1286
97. S.Z. Imam, G.D. Newport, Y. Itzhak, J.L. Cadet, F. Islam, W. Slikker Jr., and S.F. Ali Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase J. Neurochem. 76 2001 745 749
98. Y. Itzhak, and S.F. Ali Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs Pharmacol. Ther. 109 2006 246 262
99. A. Iwashita, K. Mihara, S. Yamazaki, S. Matsuura, J. Ishida, H. Yamamoto, K. Hattori, N. Matsuoka, and S. Mutoh A new poly(ADP-ribose) polymerase inhibitor, FR261529 [2-(4-chlorophenyl)-5-quinoxalinecarboxamide], ameliorates methamphetamine-induced dopaminergic neurotoxicity in mice J. Pharmacol. Exp. Ther. 310 2004 1114 1124
100. E.J. Jaehne, A. Salem, and R.J. Irvine Pharmacological and behavioral determinants of cocaine, methamphetamine, 3,4-Methylenedioxymethamphetamine, and para-methoxyamphetamine-induced hyperthermia Psychopharmacology (Berl) 194 2007 41 52
101. S. Jayanthi, X. Deng, M. Bordelon, M.T. McCoy, and J.L. Cadet Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex FASEB J. 15 10 2001 1745 1752
102. S. Jayanthi, X. Deng, P.A. Noailles, B. Ladenheim, and J.L. Cadet Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades FASEB J. 18 2 2004 238 251
103. E.A. Johnson, J.P. O'Callaghan, and D.B. Miller Brain concentrations of d-MDMA are increased after stress Psychopharmacology (Berl) 173 2004 278 286
104. P.W. Kalivas, R.T. Lalumiere, L. Knackstedt, and H. Shen Glutamate transmission in addiction Neuropharmacology 56 Suppl. 1 2009 169 173
105. P.E. Karper, H. De la Rosa, E.R. Newman, C.M. Krall, A. Nazarian, S.A. McDougall, and C.A. Crawford Role of D1-like receptors in amphetamine-induced behavioral sensitization: a study using D1A receptor knockout mice Psychopharmacology (Berl) 159 2002 407 414
106. M.R. Kilbourn, and E.F. Domino Increased in vivo [11C]raclopride binding to brain dopamine receptors in amphetamine-treated rats Eur. J. Pharmacol. 654 2011 254 257
107. A.M. Kindlundh-Högberg, A. Blomqvist, R. Malki, and H.B. Schiöth Extensive neuroadaptive changes in cortical gene-transcript expressions of the glutamate system in response to repeated intermittent MDMA administration in adolescent rats BMC Neurosci. 9 2008 39
108. E.A. Kiyatkin, and H.S. Sharma Acute methamphetamine intoxication: brain hyperthermia, blood-brain barrier, brain edema, and morphological cell abnormalities Int. Rev. Neurobiol. 88 2009 65 100
109. S. Klongpanichapak, P. Govitrapong, S.K. Sharma, and M. Ebadi Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q10 Neurochem. Res. 31 2006 303 311
110. S.H. Kollins, E.K. MacDonald, and C.R. Rush Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review Pharmacol. Biochem. Behav. 68 2001 611 627
111. S.M. Kousik, T.C. Napier, and P.M. Carvey The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation Front. Pharmacol. 3 2012 121
112. I.N. Krasnova, B. Ladenheim, and J.L. Cadet Amphetamine induces apoptosis of medium spiny striatal projection neurons via the mitochondria-dependent pathway FASEB J. 19 2005 851 853
113. I.N. Krasnova, and J.L. Cadet Methamphetamine toxicity and messengers of death Brain Res. Rev. 60 2009 379 407
114. R. Kuczenski, and D.S. Segal Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine J. Neurochem. 68 1997 2032 2037
115. D.Y. Kuo, S.F. Yang, S.C. Chu, C.H. Chen, and Y.S. Hsieh Amphetamine-evoked changes of oxidative stress and neuropeptide Y gene expression in hypothalamus: regulation by the protein kinase C-delta signaling Chem. Biol. Interact. 180 2009 193 201
116. G. Lacan, M. Hadamitzky, R. Kuczenski, and W.P. Melega Alterations in the striatal dopamine system during intravenous methamphetamine exposure: effects of contingent and noncontingent administration Synapse 67 2013 476 488
117. B. Ladenheim, I.N. Krasnova, X. Deng, J.M. Oyler, A. Polettini, T.H. Moran, M.A. Huestis, and J.L. Cadet Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6 Mol. Pharmacol. 58 2000 1247 1256
118. D.C. Lagace, J.K. Yee, C.A. Bolanos, and A.J. Eisch Juvenile administration of methylphenidate attenuates adult hippocampal neurogenesis Biol. Psychiatry 60 2006 1121 1130
119. B. Lee, E.D. London, R.A. Poldrack, J. Farahi, A. Nacca, J.R. Monterosso, J.A. Mumford, A.V. Bokarius, M. Dahlbom, J. Mukherjee, R.M. Bilder, A.L. Brody, and M.A. Mandelkern Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity J. Neurosci. 29 2009 14734 14740
120. C.T. Lee, J. Chen, T. Hayashi, S.Y. Tsai, J.F. Sanchez, S.L. Errico, R. Amable, T.P. Su, R.H. Lowe, M.A. Huestis, J. Shen, K.G. Becker, H.M. Geller, and W.J. Freed A mechanism for the inhibition of neural progenitor cell proliferation by cocaine PLoS Med. 5 2008 e117
121. J. Lee, C.L. Parish, D. Tomas, and M.K. Horne Chronic cocaine administration reduces striatal dopamine terminal density and striatal dopamine release which leads to drug-seeking behaviour Neuroscience 174 2011 143 150
122. T.H. Lee, C.H. Lee, I.H. Kim, B.C. Yan, J.H. Park, S.H. Kwon, O.K. Park, J.H. Ahn, J.H. Cho, M.H. Won, and S.K. Kim Effects of ADHD therapeutic agents, methylphenidate and atomoxetine, on hippocampal neurogenesis in the adolescent mouse dentate gyrus Neurosci. Lett. 524 2012 84 88
123. E. Lehrmann, J. Oyler, M.P. Vawter, T.M. Hyde, B. Kolachana, J.E. Kleinman, M.A. Huestis, K.G. Becker, and W.J. Freed Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse Pharmacogenomics J. 3 2003 27 40
124. L.R. Leon Invited review: cytokine regulation of fever: studies using gene knockout mice J. Appl. Physiol. 92 2002 2648 2655
125. M.S. Levi, B. Divine, J.P. Hanig, D.R. Doerge, M.M. Vanlandingham, N.I. George, N.C. Twaddle, and J.F. Bowyer A comparison of methylphenidate-, amphetamine-, and methamphetamine-induced hyperthermia and neurotoxicity in male Sprague-Dawley rats during the waking (lights off) cycle Neurotoxicol. Teratol. 34 2012 253 262
126. I.H. Li, W.S. Huang, C.Y. Shiue, Y.Y. Huang, R.S. Liu, S.C. Chyueh, S.H. Hu, M.H. Liao, L.H. Shen, J.C. Liu, and K.H. Ma Study on the neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PET Neuroimage 49 2010 1259 1270
127. 2-like receptor modulation of glutamate and dopamine neurotransmission within the mesocorticolimbic system J. Neurochem. 119 2011 332 341
128. S.A. Lloyd, Z.R. Balest, F.S. Corotto, and R.J. Smeyne Cocaine selectively increases proliferation in the adult murine hippocampus Neurosci. Lett. 485 2010 112 116
129. W. Lu, and M.E. Wolf Repeated amphetamine administration alters AMPA receptor subunit expression in rat nucleus accumbens and medial prefrontal cortex Synapse 32 1999 119 131
130. M. Maćkowiak, M. Grzegorzewska, B. Budziszewska, A. Chocyk, G. Hess, and K. Wedzony Cocaine decreases the expression of PSA-NCAM protein and attenuates long-term potentiation via glucocorticoid receptors in the rat dentate gyrus Eur. J. Neurosci. 27 2008 2928 2937
131. S.D. Mahajan, R. Aalinkeel, D.E. Sykes, J.L. Reynolds, B. Bindukumar, A. Adal, M. Qi, J. Toh, G. Xu, P.N. Prasad, and S.A. Schwartz Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: implication for HIV-1 neuropathogenesis in the context of drug abuse Brain Res. 1203 2008 133 148
132. J.E. Malberg, and L.S. Seiden Small changes in ambient temperature cause large changes in 3,4-Methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat J. Neurosci. 18 1998 5086 5094
133. C.D. Mandyam, S. Wee, E.F. Crawford, A.J. Eisch, H.N. Richardson, and G.F. Koob Varied access to intravenous methamphetamine self-administration differentially alters adult hippocampal neurogenesis Biol. Psychiatry 64 2008 958 965
134. L. Mao, and J.Q. Wang Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration Synapse 41 2001 230 240
135. L.M. Mao, W. Wang, X.P. Chu, G.C. Zhang, X.Y. Liu, Y.J. Yang, M. Haines, C.J. Papasian, E.E. Fibuch, S. Buch, J.G. Chen, and J.Q. Wang Stability of surface NMDA receptors controls synaptic and behavioral adaptations to amphetamine Nat. Neurosci. 12 2009 602 610
136. K.A. Mark, M.S. Quinton, S.J. Russek, and B.K. Yamamoto Dynamic changes in vesicular glutamate transporter 1 function and expression related to methamphetamine-induced glutamate release J. Neurosci. 27 2007 6823 6831
137. M.R. Martins, A. Reinke, F.C. Petronilho, K.M. Gomes, F. Dal-Pizzol, and J. Quevedo Methylphenidate treatment induces oxidative stress in young rat brain Brain Res. 1078 2006 189 197
138. T. Martins, S. Baptista, J. Goncalves, E. Leal, N. Milhazes, F. Borges, C.F. Ribeiro, O. Quintela, E. Lendoiro, M. Lopez-Rivadulla, A.F. Ambrosio, and A.P. Silva Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus: role of tight junction proteins and matrix metalloproteinase-9 Brain Res. 1411 2011 28 40
139. T. Martins, T. Burgoyne, B.A. Kenny, N. Hudson, C.E. Futter, A.F. Ambrosio, A.P. Silva, J. Greenwood, and P. Turowski Methamphetamine-induced nitric oxide promotes vesicular transport in blood-brain barrier endothelial cells Neuropharmacology 65 2013 74 82
140. A.J. McGeehan, P.H. Janak, and M.F. Olive Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, D-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice Psychopharmacology (Berl) 174 2004 266 273
141. M. Miguéns, N. Del Olmo, A. Higuera-Matas, I. Torres, C. García-Lecumberri, and E. Ambrosio Glutamate and aspartate levels in the nucleus accumbens during cocaine self-administration and extinction: a time course microdialysis study Psychopharmacology (Berl) 196 2008 303 313
142. J.G. Millichap Methylphenidate role in Tourette syndrome prevalence J. R. Soc. Med. 92 1999 156
143. M. Miranda, F. Bosch-Morell, S. Johnsen-Soriano, J. Barcia, I. Almansa, S. Asensio, J. Araiz, A. Messeguer, and F.J. Romero Oxidative stress in rat retina and hippocampus after chronic MDMA ('ecstasy') administration Neurochem. Res. 32 2007 1156 1162
144. A. Mirecki, P. Fitzmaurice, L. Ang, K.S. Kalasinsky, F.J. Peretti, S.S. Aiken, D.J. Wickham, A. Sherwin, J.N. Nobrega, H.J. Forman, and S.J. Kish Brain antioxidant systems in human methamphetamine users J. Neurochem. 89 2004 1396 1408
145. M.M. Mitler, R. Shafor, R. Hajdukovich, R.M. Timms, and C.P. Browman Treatment of narcolepsy: objective studies on methylphenidate, pemoline, and protriptyline Sleep 9 1986 260 264
146. Y. Morishima, T. Miyakawa, T. Furuyashiki, Y. Tanaka, H. Mizuma, and S. Nakanishi Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice Proc. Natl. Acad. Sci. U. S. A. 102 2005 4170 4175
147. M. Mueller, J. Yuan, A. Felim, A. Neudörffer, F.T. Peters, H.H. Maurer, U.D. McCann, M. Largeron, and G.A. Ricaurte Further studies on the role of metabolites in (+/-)-3,4-Methylenedioxymethamphetamine-induced serotonergic neurotoxicity Drug Metab. Dispos. 37 2009 2079 2086
148. C.P. Müller, R.J. Carey, J.B. Salloum, and J.P. Huston Serotonin1A-receptor agonism attenuates the cocaine-induced increase in serotonin levels in the hippocampus and nucleus accumbens but potentiates hyperlocomotion: an in vivo microdialysis study Neuropharmacology 44 2003 592 603
149. M. Muriach, R. López-Pedrajas, J.M. Barcia, M.V. Sanchez-Villarejo, I. Almansa, and F.J. Romero Cocaine causes memory and learning impairments in rats: involvement of nuclear factor kappa B and oxidative stress, and prevention by topiramate J. Neurochem. 114 2010 675 684
150. A. Nakajima, K. Yamada, T. Nagai, T. Uchiyama, Y. Miyamoto, T. Mamiya, J. He, A. Nitta, M. Mizuno, M.H. Tran, A. Seto, M. Yoshimura, K. Kitaichi, T. Hasegawa, K. Saito, Y. Yamada, M. Seishima, K. Sekikawa, H.C. Kim, and T. Nabeshima Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity J. Neurosci. 24 2004 2212 2225
151. J.F. Nash, and B.K. Yamamoto Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-Methylenedioxymethamphetamine Brain Res. 581 1992 237 243
152. B. Ng Methylphenidate and depression J. Clin. Psychopharmacol. 28 2008 116 117 (author reply 117-118)
153. W.L. Nixdorf, K.B. Burrows, G.A. Gudelsky, and B.K. Yamamoto Enhancement of 3,4-Methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate J. Neurochem. 77 2001 647 654
154. M.A. Noonan, S.E. Bulin, D.C. Fuller, and A.J. Eisch Reduction of adult hippocampal neurogenesis confers vulnerability in an animal model of cocaine addiction J. Neurosci. 30 2010 304 315
155. M.A. Noonan, K.H. Choi, D.W. Self, and A.J. Eisch Withdrawal from cocaine self-administration normalizes deficits in proliferation and enhances maturity of adult-generated hippocampal neurons J. Neurosci. 28 2008 2516 2526
156. R. Numa, M. Baron, R. Kohen, and R. Yaka Tempol attenuates cocaine-induced death of PC12 cells through decreased oxidative damage Eur. J. Pharmacol. 650 2011 157 162
157. Y. Numachi, A. Ohara, M. Yamashita, S. Fukushima, H. Kobayashi, H. Hata, H. Watanabe, F.S. Hall, K.P. Lesch, D.L. Murphy, G.R. Uhl, and I. Sora Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters Eur. J. Pharmacol. 572 2007 120 128
158. S.J. O'Dell, F.B. Weihmuller, and J.F. Marshall Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists J. Neurochem. 60 1993 1792 1799
159. E. O'Shea, V. Sanchez, L. Orio, I. Escobedo, A.R. Green, and M.I. Colado 3,4-Methylenedioxymethamphetamine increases pro-interleukin-1beta production and caspase-1 protease activity in frontal cortex, but not in hypothalamus, of Dark Agouti rats: role of interleukin-1beta in neurotoxicity Neuroscience 135 2005 1095 1105
160. L. Orio, E. O'Shea, V. Sanchez, J.M. Pradillo, I. Escobedo, J. Camarero, M.A. Moro, A.R. Green, and M.I. Colado 3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion J. Neurochem. 8 2004 1445 1453
161. L. Orio, N. Llopis, E. Torres, M. Izco, E. O'Shea, and M.I. Colado A study on the mechanisms by which minocycline protects against MDMA ('ecstasy')-induced neurotoxicity of 5-HT cortical neurons Neurotox. Res. 18 2010 187 199
162. M. Park, B. Hennig, and M. Toborek Methamphetamine alters occludin expression via NADPH oxidase-induced oxidative insult and intact caveolae J. Cell Mol. Med. 16 2 2012 362 375
163. F.C. Pereira, M.R. Rolo, E. Marques, V.M. Mendes, C.F. Ribeiro, S.F. Ali, T. Morgadinho, and T.R. Macedo Acute increase of the glutamate-glutamine cycling in discrete brain areas after administration of a single dose of amphetamine Ann. N. Y. Acad. Sci. 1139 2008 212 221
164. L. Pomierny-Chamioło, A. Moniczewski, K. Wydra, A. Suder, and M. Filip Oxidative stress biomarkers in some rat brain structures and peripheral organs underwent cocaine Neurotox. Res. 23 2013 92 102
165. E. Puerta, I. Hervias, B. Goñi-Allo, S.F. Zhang, J. Jordán, A.A. Starkov, and N. Aguirre Methylenedioxymethamphetamine inhibits mitochondrial complex I activity in mice: a possible mechanism underlying neurotoxicity Br. J. Pharmacol. 160 2010 233 245
166. S.H. Ramirez, R. Potula, S. Fan, T. Eidem, A. Papugani, N. Reichenbach, H. Dykstra, B.B. Weksler, I.A. Romero, P.O. Couraud, and Y. Persidsky Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells J. Cereb. Blood Flow Metab. 29 2009 1933 1945
167. B.A. Rasmussen, E. Kim, E.M. Unterwald, and S.M. Rawls Methanandamide attenuates cocaine-induced hyperthermia in rats by a cannabinoid CB(1)-dopamine D(2) receptor mechanism Brain Res. 1260 2009 7 14
168. P. Recinto, A.R. Samant, G. Chavez, A. Kim, C.J. Yuan, M. Soleiman, Y. Grant, S. Edwards, S. Wee, G.F. Koob, O. George, and C.D. Mandyam Levels of neural progenitors in the hippocampus predict memory impairment and relapse to drug seeking as a function of excessive methamphetamine self-administration Neuropsychopharmacology 37 2012 1275 1287
169. M.S. Reid, K. Hsu Jr., and S.P. Berger Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine Synapse 27 1997 95 105
170. E.L. Riddle, G.R. Hanson, and A.E. Fleckenstein Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2 Eur. J. Pharmacol. 571 2007 25 28
171. C. Rocher, and A.M. Gardier Effects of repeated systemic administration of d-Fenfluramine on serotonin and glutamate release in rat ventral hippocampus: comparison with methamphetamine using in vivo microdialysis Naunyn Schmiedebergs Arch. Pharmacol. 363 2001 422 428
172. S. Sadasivan, B.B. Pond, A.K. Pani, C. Qu, Y. Jiao, and R.J. Smeyne Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice PLoS One 7 2012 e33693
173. A.C. Santucci, S. Capodilupo, J. Bernstein, M. Gomez-Ramirez, R. Milefsky, and H. Mitchell Cocaine in adolescent rats produces residual memory impairments that are reversible with time Neurotoxicol. Teratol. 26 2004 651 661
174. F. Sarti, S.L. Borgland, V.N. Kharazia, and A. Bonci Acute cocaine exposure alters spine density and long-term potentiation in the ventral tegmental area Eur. J. Neurosci. 26 2007 749 756
175. A.T. Schaefers, G. Teuchert-Noodt, F. Bagorda, and S. Brummelte Effect of postnatal methamphetamine trauma and adolescent methylphenidate treatment on adult hippocampal neurogenesis in gerbils Eur. J. Pharmacol. 616 2009 86 90
176. E.B. Scherer, C. Matte, A.G. Ferreira, K.M. Gomes, C.M. Comim, C. Mattos, J. Quevedo, E.L. Streck, and A.T. Wyse Methylphenidate treatment increases Na(+), K (+)-ATPase activity in the cerebrum of young and adult rats J. Neural Transm. 116 2009 1681 1687
177. F. Schmitz, E.B. Scherer, F.R. Machado, A.A. da Cunha, B. Tagliari, C.A. Netto, and A.T. Wyse Methylphenidate induces lipid and protein damage in prefrontal cortex, but not in cerebellum, striatum and hippocampus of juvenile rats Metab. Brain Dis. 27 2012 605 612
178. C. Shaffer, M.L. Guo, E.E. Fibuch, L.M. Mao, and J.Q. Wang Regulation of group I metabotropic glutamate receptor expression in the rat striatum and prefrontal cortex in response to amphetamine in vivo Brain Res. 1326 2010 184 192
179. M. Shankaran, B.K. Yamamoto, and G.A. Gudelsky Ascorbic acid prevents 3,4-Methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT Synapse 40 2001 55 64
180. H.S. Sharma, and S.F. Ali Alterations in blood-brain barrier function by morphine and methamphetamine Ann. N. Y. Acad. Sci. 1074 2006 198 224
181. H.S. Sharma, P.O. Sjoquist, and S.F. Ali Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290/51 Curr. Pharm. Des. 13 2007 1903 1923
182. H.S. Sharma, and S.F. Ali Acute administration of 3,4-Methylenedioxymethamphetamine induces profound hyperthermia, blood-brain barrier disruption, brain edema formation, and cell injury Ann. N. Y. Acad. Sci. 1139 2008 242 258
183. E.J. Shin, C.X. Duong, X.K. Nguyen, Z. Li, G. Bing, J.H. Bach, D.H. Park, K. Nakayama, S.F. Ali, A.G. Kanthasamy, J.L. Cadet, T. Nabeshima, and H.C. Kim Role of oxidative stress in methamphetamine-induced dopaminergic toxicity mediated by protein kinase Cdelta Behav. Brain Res. 232 2012 98 113
184. A.P. Silva, T. Martins, S. Baptista, J. Goncalves, F. Agasse, and J.O. Malva Brain injury associated with widely abused amphetamines: neuroinflammation, neurogenesis and blood-brain barrier Curr. Drug. Abuse Rev. 3 2010 239 254
185. P.F. Simões, A.P. Silva, F.C. Pereira, E. Marques, S. Grade, N. Milhazes, F. Borges, C.F. Ribeiro, and T.R. Macedo Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory Neuroscience 150 2007 433 441
186. P.F. Simões, A.P. Silva, F.C. Pereira, E. Marques, N. Milhazes, F. Borges, C.F. Ribeiro, and T.R. Macedo Methamphetamine changes NMDA and AMPA glutamate receptor subunit levels in the rat striatum and frontal cortex Ann. N. Y. Acad. Sci. 1139 2008 232 241
187. K.J. Smith, T.R. Butler, and M.A. Prendergast Inhibition of sigma-1 receptor reduces N-methyl-D-aspartate induced neuronal injury in methamphetamine-exposed and -naive hippocampi Neurosci. Lett. 481 2010 144 148
188. P.K. Sonsalla, D.E. Riordan, and R.E. Heikkila Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice J. Pharmacol. Exp. Ther. 256 1991 506 512
189. P.L. Soto, K.M. Wilcox, Y. Zhou, A. Kumar, N.A. Ator, M.A. Riddle, D.F. Wong, and M.R. Weed Long-term exposure to oral methylphenidate or dl-amphetamine mixture in peri-adolescent rhesus monkeys: effects on physiology, behavior, and dopamine system development Neuropsychopharmacology 37 2012 2566 2579
190. J.E. Sprague, M.L. Banks, V.J. Cook, and E.M. Mills Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) J. Pharmacol. Exp. Ther. 305 2003 159 166
191. K. Sriram, D.B. Miller, and J.P. O'Callaghan Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha J. Neurochem. 96 2006 706 718
192. E. Sudai, O. Croitoru, A. Shaldubina, L. Abraham, I. Gispan, Y. Flaumenhaft, I. Roth-Deri, N. Kinor, S. Aharoni, M. Ben-Tzion, and G. Yadid High cocaine dosage decreases neurogenesis in the hippocampus and impairs working memory Addict. Biol. 16 2011 251 260
193. D. Sulzer, M.S. Sonders, N.W. Poulsen, and A. Galli Mechanisms of neurotransmitter release by amphetamines: a review Prog. Neurobiol. 75 2005 406 433
194. N. Suto, L.E. Ecke, Z.B. You, and R.A. Wise Extracellular fluctuations of dopamine and glutamate in the nucleus accumbens core and shell associated with lever-pressing during cocaine self-administration, extinction, and yoked cocaine administration Psychopharmacology (Berl) 211 2010 267 275
195. T. Tanaka, N. Kai, K. Kobayashi, Y. Takano, and N. Hironaka Up-regulation of dopamine D1 receptor in the hippocampus after establishment of conditioned place preference by cocaine Neuropharmacology 61 2011 842 848
196. G. Teuchert-Noodt, R.R. Dawirs, and K. Hildebrandt Adult treatment with methamphetamine transiently decreases dentate granule cell proliferation in the gerbil hippocampus J. Neural Transm. 107 2000 133 143
197. P.K. Thanos, M. Michaelides, H. Benveniste, G.J. Wang, and N.D. Volkow The effects of cocaine on regional brain glucose metabolism is attenuated in dopamine transporter knockout mice Synapse 62 2008 319 324
198. D.M. Thomas, D.M. Francescutti-Verbeem, and D.M. Kuhn The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity J. Neurochem. 105 2008 605 616
199. J. Tocharus, C. Khonthun, S. Chongthammakun, and P. Govitrapong Melatonin attenuates methamphetamine-induced overexpression of pro-inflammatory cytokines in microglial cell lines J. Pineal. Res. 48 2010 347 352
200. E. Torres, M.D. Gutierrez-Lopez, E. Borcel, I. Peraile, A. Mayado, E. O'Shea, and M.I. Colado Evidence that MDMA ('ecstasy') increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain J. Neurochem. 113 2010 67 78
201. E. Torres, M.D. Gutierrez-Lopez, A. Mayado, A. Rubio, E. O'Shea, and M.I. Colado Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity J. Neuroinflamm. 8 2011 53
202. I. Tulloch, N. Ghazaryan, I. Mexhitaj, D. Ordonez, and J.A. Angulo Role of neurokinin-1 and dopamine receptors on the striatal methamphetamine-induced proliferation of new cells in mice Brain Res. 1399 2011 33 39
203. K. Uemura, T. Aki, K. Yamaguchi, and K. Yoshida Protein kinase C-epsilon protects PC12 cells against methamphetamine-induced death: possible involvement of suppression of glutamate receptor Life Sci. 72 2003 1595 1607
204. A. Urrutia, A. Rubio-Araiz, M.D. Gutierrez-Lopez, A. ElAli, D.M. Hermann, E. O'Shea, and M.I. Colado A study on the effect of JNK inhibitor, SP600125, on the disruption of blood-brain barrier induced by methamphetamine Neurobiol. Dis. 50 2013 49 58
205. A. Venkatesan, L. Uzasci, Z. Chen, L. Rajbhandari, C. Anderson, M.H. Lee, M.A. Bianchet, R. Cotter, H. Song, and A. Nath Impairment of adult hippocampal neural progenitor proliferation by methamphetamine: role for nitrotyrosination Mol. Brain 4 2011 28
206. G.C. Verster, and A.A. van Niekerk Moral perspectives on stimulant use by healthy students S. Afr. Med. J. 102 2012 909 911
207. N.D. Volkow, G.J. Wang, J.S. Fowler, S.J. Gatley, J. Logan, Y.S. Ding, R. Hitzemann, and N. Pappas Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate Am. J. Psychiatry 155 10 1998 1325 1331
208. N.D. Volkow, L. Chang, G.J. Wang, J.S. Fowler, Y.S. Ding, M. Sedler, J. Logan, D. Franceschi, J. Gatley, R. Hitzemann, A. Gifford, C. Wong, and N. Pappas Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex Am. J. Psychiatry 158 2001 2015 2021
209. N.D. Volkow, L. Chang, G.J. Wang, J.S. Fowler, D. Franceschi, M. Sedler, S.J. Gatley, E. Miller, R. Hitzemann, Y.S. Ding, and J. Logan Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence J. Neurosci. 21 2001 9414 9418
210. N.D. Volkow, G. Wang, J.S. Fowler, J. Logan, M. Gerasimov, L. Maynard, Y. Ding, S.J. Gatley, A. Gifford, and D. Franceschi Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain J. Neurosci. 21 2001 RC121
211. N.D. Volkow, G.J. Wang, D. Tomasi, S.H. Kollins, T.L. Wigal, J.H. Newcorn, F.W. Telang, J.S. Fowler, J. Logan, C.T. Wong, and J.M. Swanson Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder J. Neurosci. 32 2012 841 849
212. F.J. Wan, H.C. Lin, K.L. Huang, C.J. Tseng, and C.S. Wong Systemic administration of d-amphetamine induces long-lasting oxidative stress in the rat striatum Life Sci. 66 2000 PL205 PL212
213. S.J. Wanchoo, A.C. Swann, and N. Dafny Descending glutamatergic pathways of PFC are involved in acute and chronic action of methylphenidate Brain Res. 1301 2009 68 79
214. J. Wang, and J.A. Angulo Synergism between methamphetamine and the neuropeptide substance P on the production of nitric oxide in the striatum of mice Brain Res. 1369 2011 131 139
215. X. Wang, M.H. Baumann, H. Xu, and R.B. Rothman 3,4-Methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein Synapse 53 2004 240 248
216. X.Q. Wang, Y.P. Peng, J.H. Lu, B.B. Cao, and Y.H. Qiu Neuroprotection of interleukin-6 against NMDA attack and its signal transduction by JAK and MAPK Neurosci. Lett. 450 2 2009 122 126
217. M.W. Warren, F.H. Kobeissy, M.C. Liu, R.L. Hayes, M.S. Gold, and K.K. Wang Concurrent calpain and caspase-3 mediated proteolysis of alpha II-spectrin and tau in rat brain after methamphetamine exposure: a similar profile to traumatic brain injury Life Sci. 78 2005 301 309
218. M.W. Warren, W. Zheng, F.H. Kobeissy, M. Cheng Liu, R.L. Hayes, M.S. Gold, S.F. Larner, and K.K. Wang Calpain- and caspase-mediated alphaII-spectrin and tau proteolysis in rat cerebrocortical neuronal cultures after ecstasy or methamphetamine exposure Int. J. Neuropsychopharmacol. 10 2007 479 489
219. I. Willuhn, M.J. Wanat, J.J. Clark, and P.E. Phillips Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse Curr. Top. Behav. Neurosci. 3 2010 29 71
220. C.W. Wu, Y.H. Ping, J.C. Yen, C.Y. Chang, S.F. Wang, C.L. Yeh, C.W. Chi, and H.C. Lee Enhanced oxidative stress and aberrant mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells during methamphetamine induced apoptosis Toxicol. Appl. Pharmacol. 220 2007 243 251
221. M. Yamaguchi, T. Suzuki, T. Seki, T. Namba, R. Juan, H. Arai, T. Hori, and T. Asada Repetitive cocaine administration decreases neurogenesis in adult rat hippocampus Ann. N. Y. Acad. Sci. 1025 2004 351 362
222. M. Yamaguchi, T. Suzuki, T. Seki, T. Namba, J. Liu, H. Arai, T. Hori, and T. Shiga Decreased cell proliferation in the dentate gyrus of rats after repeated administration of cocaine Synapse 58 2005 63 71
223. T. Yamaguchi, Y. Kuraishi, M. Minami, S. Nakai, Y. Hirai, and M. Satoh Methamphetamine-induced expression of interleukin-1 beta mRNA in the rat hypothalamus Neurosci. Lett. 128 1991 90 92
224. B.K. Yamamoto, A. Moszczynska, and G.A. Gudelsky Amphetamine toxicities: classical and emerging mechanisms Ann. N. Y. Acad. Sci. 1187 2010 101 121
225. Y. Yang, H. Yao, Y. Lu, C. Wang, and S. Buch Cocaine potentiates astrocyte toxicity mediated by human immunodeficiency virus (HIV-1) protein gp120 PLoS One 5 2010 e13427
226. H. Yao, K. Kim, M. Duan, T. Hayashi, M. Guo, S. Morgello, A. Prat, J. Wang, T.P. Su, and S. Buch Cocaine hijacks σ1 receptor to initiate induction of activated leukocyte cell adhesion molecule: implication for increased monocyte adhesion and migration in the CNS J. Neurosci. 31 2011 5942 5955
227. H. Yao, M. Duan, and S. Buch Cocaine-mediated induction of platelet-derived growth factor: implication for increased vascular permeability Blood 117 2011 2538 2547
228. C.J. Yuan, J.M. Quiocho, A. Kim, S. Wee, and C.D. Mandyam Extended access methamphetamine decreases immature neurons in the hippocampus which results from loss and altered development of neural progenitors without altered dynamics of the S-phase of the cell cycle Pharmacol. Biochem. Behav. 100 2011 98 108
229. J. Yuan, G. Hatzidimitriou, P. Suthar, M. Mueller, U. McCann, and G. Ricaurte Relationship between temperature, dopaminergic neurotoxicity, and plasma drug concentrations in methamphetamine-treated squirrel monkeys J. Pharmacol. Exp. Ther. 316 2006 1210 1218
230. L. Zhang, D. Looney, D. Taub, S.L. Chang, D. Way, M.H. Witte, M.C. Graves, and M. Fiala Cocaine opens the blood-brain barrier to HIV-1 invasion J. Neurovirol. 4 1998 619 626
231. Y. Zhang, T.M. Loonam, P.A. Noailles, and J.A. Angulo Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions Ann. N. Y. Acad. Sci. 937 2001 93 120
232. J.P. Zhu, W. Xu, and J.A. Angulo Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice Brain Res. 1049 2005 171 181
233. H.J. Zhu, J.S. Wang, C.L. DeVane, R.L. Williard, J.L. Donovan, L.D. Middaugh, B.B. Gibson, K.S. Patrick, and J.S. Markowitz The role of the polymorphic efflux transporter P-glycoprotein on the brain accumulation of d-methylphenidate and d-amphetamine Drug Metab. Dispos. 34 2006 1116 1121